U.S. Menopause Market Size, Share & Trends Report

U.S. Menopause Market (2025 - 2033) Size, Share & Trends Analysis Report By Type (Hormonal, Non-Hormonal, and Dietary Supplements), By Country (West, South, Midwest), And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Market Definitions
                    1.3. Information Procurement
                        1.3.1. Purchased Database
                        1.3.2. GVR’s Internal Database
                        1.3.3. Secondary Sources & Third-Party Perspectives
                        1.3.4. Primary Research
                        1.3.5. Details of Primary Research
                    1.4. Information Analysis
                        1.4.1. Data Analysis Models
                    1.5. Market Formulation & Data Visualization
                        1.5.1. Commodity Flow Analysis
                    1.6. Data Validation & Publishing
                    1.7. List of Secondary Sources
                    1.8. Research Objectives
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segmental Snapshot
                    2.3. Competitive Insights Snapshot
Chapter 3. Market Variables, Trends, and Scope
                    3.1. Market Lineage
                        3.1.1. Parent Market Analysis
                        3.1.2. Ancillary Market Analysis
                    3.2. U.S. Menopause Market- Market Dynamics
                        3.2.1. Market Driver Analysis
                        3.2.2. Market Restraint Analysis
                        3.2.3. Market Opportunity Analysis
                        3.2.4. Market Challenges Analysis
                    3.3. Covid-19 Impact Analysis
                    3.4. Regulatory & Reimbursement Scenario
                    3.5. Business Environmental Tools Analysis: U.S. Menopause Market
                        3.5.1. Porter’s Five Forces Analysis
                        3.5.2. PESTLE Analysis
Chapter 4. U.S. Menopause Market: Type Estimates & Trend Analysis
                    4.1. U.S. Menopause Market, By Type: Key Takeaways
                    4.2. U.S. Menopause Market: Type Movement & Market Share Analysis, 2024 & 2033
                    4.3. Hormonal
                        4.3.1. Hormonal Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                    4.4. Non-Hormonal
                        4.4.1. Non-Hormonal Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                    4.5. Dietary Supplements
                        4.5.1. Dietary Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 5. U.S. Menopause Market: Country Estimates & Trend Analysis
                    5.1. U.S. Menopause Market, By Regional: Key Takeaways
                    5.2. U.S. Menopause Market: Regional Movement & Market Share Analysis, 2024 & 2033
                    5.3. West
                        5.3.1. West Menopause Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                    5.4. Southeast
                        5.4.1. Southeast Menopause Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                    5.5. Southwest
                        5.5.1. Southwest Menopause Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                    5.6. Midwest
                        5.6.1. Midwest Menopause Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
                    5.7. Northeast
                        5.7.1. Northeast Menopause Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 6. Competitive Landscape
                    6.1. Company Categorization
                    6.2. Company Market Position Analysis
                    6.3. Strategy Mapping
                    6.4. Company Profiles
                        6.4.1. Pfizer Inc.
                            6.4.1.1. Overview
                            6.4.1.2. Financial Performance
                            6.4.1.3. Product Benchmarking
                            6.4.1.4. Strategic Initiatives
                        6.4.2. Novo Nordisk A/S
                            6.4.2.1. Overview
                            6.4.2.2. Financial Performance
                            6.4.2.3. Product Benchmarking
                            6.4.2.4. Strategic Initiatives
                        6.4.3. TherapeuticsMD
                            6.4.3.1. Overview
                            6.4.3.2. Financial Performance
                            6.4.3.3. Product Benchmarking
                            6.4.3.4. Strategic Initiatives
                        6.4.4. Bayer AG
                            6.4.4.1. Overview
                            6.4.4.2. Financial Performance
                            6.4.4.3. Product Benchmarking
                            6.4.4.4. Strategic Initiatives
                        6.4.5. AbbVie, Inc.
                            6.4.5.1. Overview
                            6.4.5.2. Financial Performance
                            6.4.5.3. Product Benchmarking
                            6.4.5.4. Strategic Initiatives
                        6.4.6. Pure Encapsulations, LLC.
                            6.4.6.1. Overview
                            6.4.6.2. Financial Performance
                            6.4.6.3. Product Benchmarking
                            6.4.6.4. Strategic Initiatives
                        6.4.7. PADAGIS LLC
                            6.4.7.1. Overview
                            6.4.7.2. Financial Performance
                            6.4.7.3. Product Benchmarking
                            6.4.7.4. Strategic Initiatives


List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 U.S. menopause market revenue estimates and forecast, by type, 2021 - 2033 (USD Billion)
Table 4 U.S. menopause market revenue estimates and forecast, by regional, 2021 - 2033 (USD Billion)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. menopause market: market outlook
Fig. 9 U.S. menopause competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 U.S. menopause market driver impact
Fig. 14 U.S. menopause market restraint impact
Fig. 15 U.S. menopause market: Treatment movement analysis
Fig. 16 U.S. menopause market: Treatment outlook and key takeaways
Fig. 17 Dietary supplements market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 18 OTC pharma products estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 19 Hormonal estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 20 Non hormonal market estimates and forecasts, 2021 - 2033 (USD Billion)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Trusted market insights - try a free sample

See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.

logo
GDPR & CCPA Compliant
logo
ISO 9001 Certified
logo
ISO 27001 Certified
logo
ESOMAR Member
Grand View Research is trusted by industry leaders worldwide
client logo
client logo
client logo
client logo
client logo
client logo